The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Open accessAbstract
Cancer immunotherapies that train or stimulate the inherent immunological systems to recognize, attack, and eradicate tumor cells with minimal damage to healthy cells have demonstrated promising clinical responses in recent years. However, most of these immunotherapeutic strategies only benefit a small subset of patients and cause systemic autoimmune side effects in some patients. Immunogenic cell death (ICD)‐inducing modalities not only directly kill cancer cells but also induce antitumor immune responses against a broad spectrum of solid tumors. Such strategies for generating vaccine‐like functions could be used to stimulate a “cold” tumor microenvironment to become an immunogenic, “hot” tumor microenvironment, working in synergy with immunotherapies to increase patient response rates and lead to successful treatment outcomes. This Minireview will focus on nanoparticle‐based treatment modalities that can induce and enhance ICD to potentiate cancer immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Oncology meets immunology: the cancer-immunity cycle.
Chen, D. S., & Mellman, I. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.012 · Cited by 6,929
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Shape-Controlled Synthesis of Gold and Silver Nanoparticles
Sun, Y., & Xia, Y. (2002) · Science · doi:10.1126/science.1077229 · Cited by 6,506
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Nanoparticles in Photodynamic Therapy
Lucky, S. S., Soo, K. C., & Zhang, Y. (2015) · Chemical Reviews · doi:10.1021/cr5004198 · Cited by 2,980
Photodynamic therapy and anti-tumour immunity
Castano, A. P., Mroz, P., & Hamblin, M. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1894 · Cited by 2,676
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Twyman-Saint Victor, C., Rech, A. J., Maity, A., Rengan, R., Pauken, K. E., Stelekati, E., Benci, J. L., Xu, B., Dada, H., Odorizzi, P. M., et al. (2015) · Nature · doi:10.1038/nature14292 · Cited by 2,434
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,349
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
Celli, J. P., Spring, B. Q., Rizvi, I., Evans, C. L., Samkoe, K. S., Verma, S., Pogue, B. W., & Hasan, T. (2010) · Chemical Reviews · doi:10.1021/cr900300p · Cited by 2,324
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
Deng, L., Liang, H., Burnette, B., Beckett, M., Darga, T., Weichselbaum, R. R., & Fu, Y.-X. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67313 · Cited by 2,105
Cancer immunotherapy via dendritic cells
Palucka, K., & Banchereau, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3258 · Cited by 2,049
Reddy, L. H., Arias, J. L., Nicolas, J., & Couvreur, P. (2012) · Chemical Reviews · doi:10.1021/cr300068p · Cited by 2,010
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Gubin, M. M., Zhang, X., Schuster, H., Caron, E., Ward, J. P., Noguchi, T., Ivanova, Y., Hundal, J., Arthur, C. D., Krebber, W.-J., et al. (2014) · Nature · doi:10.1038/nature13988 · Cited by 1,974
Gold nanoparticles in biomedical applications: recent advances and perspectives
Dykman, L., & Khlebtsov, N. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15166e · Cited by 1,961
How dying cells alert the immune system to danger
Kono, H., & Rock, K. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2215 · Cited by 1,737
Design of polymeric nanoparticles for biomedical delivery applications
Elsabahy, M., & Wooley, K. L. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15327k · Cited by 1,717
Adoptive immunotherapy for cancer: harnessing the T cell response
Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688
Chen, Q., Xu, L., Liang, C., Wang, C., Peng, R., & Liu, Z. (2016) · Nature Communications · doi:10.1038/ncomms13193 · Cited by 1,596
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1252 · Cited by 1,573
Yang, G., Xu, L., Chao, Y., Xu, J., Sun, X., Wu, Y., Peng, R., & Liu, Z. (2017) · Nature Communications · doi:10.1038/s41467-017-01050-0 · Cited by 1,477
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Carreno, B. M., Magrini, V., Becker-Hapak, M., Kaabinejadian, S., Hundal, J., Petti, A. A., Ly, A., Lie, W.-R., Hildebrand, W. H., Mardis, E. R., et al. (2015) · Science · doi:10.1126/science.aaa3828 · Cited by 1,285
Fever and the thermal regulation of immunity: the immune system feels the heat
Evans, S. S., Repasky, E. A., & Fisher, D. T. (2015) · Nature Reviews Immunology · doi:10.1038/nri3843 · Cited by 1,257
Nanoparticles in photodynamic therapy: An emerging paradigm
Chatterjee, D. K., Fong, L. S., & Zhang, Y. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.003 · Cited by 1,184
Immunogenic and tolerogenic cell death
Green, D. R., Ferguson, T., Zitvogel, L., & Kroemer, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2545 · Cited by 1,176
Lu, Y., Yin, Y., Mayers, B. T., & Xia, Y. (2002) · Nano Letters · doi:10.1021/nl015681q · Cited by 1,049
Duan, X., & Li, Y. (2013) · Small · doi:10.1002/smll.201201390 · Cited by 926
Self-citationCurrent Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics
Zou, L., Wang, H., He, B., Zeng, L., Tan, T., Cao, H., He, X., Zhang, Z., Guo, S., & Li, Y. (2016) · Theranostics · doi:10.7150/thno.14988 · Cited by 915
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.497 · Cited by 800
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
He, C., Duan, X., Guo, N., Chan, C., Poon, C., Weichselbaum, R. R., & Lin, W. (2016) · Nature Communications · doi:10.1038/ncomms12499 · Cited by 754
Self-citationAntigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Min, Y., Roche, K. C., Tian, S., Eblan, M. J., McKinnon, K. P., Caster, J. M., Chai, S., Herring, L. E., Zhang, L., Zhang, T., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.113 · Cited by 701
Xu, J., Xu, L., Wang, C., Yang, R., Zhuang, Q., Han, X., Dong, Z., Zhu, W., Peng, R., & Liu, Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b00715 · Cited by 695
Lan, G., Ni, K., Xu, Z., Veroneau, S. S., Song, Y., & Lin, W. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b01072 · Cited by 662
Self-citationInvestigating the Impact of Nanoparticle Size on Active and Passive Tumor Targeting Efficiency
Sykes, E. A., Chen, J., Zheng, G., & Chan, W. C. W. (2014) · ACS Nano · doi:10.1021/nn500299p · Cited by 635
Apetoh, L., Ghiringhelli, F., Tesniere, A., Criollo, A., Ortiz, C., Lidereau, R., Mariette, C., Chaput, N., Mira, J., Delaloge, S., et al. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00573.x · Cited by 574
Maximizing Tumor Immunity With Fractionated Radiation
Schaue, D., Ratikan, J. A., Iwamoto, K. S., & McBride, W. H. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.09.049 · Cited by 567
Wang, C., Xu, L., Liang, C., Xiang, J., Peng, R., & Liu, Z. (2014) · Advanced Materials · doi:10.1002/adma.201402996 · Cited by 566
Molecular mechanisms of ATP secretion during immunogenic cell death
Martins, I., Wang, Y., Michaud, M., Ma, Y., Sukkurwala, A. Q., Shen, S., Kepp, O., Métivier, D., Galluzzi, L., Perfettini, J.-L., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.75 · Cited by 563
Guo, L., Yan, D. D., Yang, D., Li, Y., Wang, X., Zalewski, O., Yan, B., & Lu, W. (2014) · ACS Nano · doi:10.1021/nn5002112 · Cited by 532
Lu, K., He, C., Guo, N., Chan, C., Ni, K., Weichselbaum, R. R., & Lin, W. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b06663 · Cited by 505
Self-citationMolecular characteristics of immunogenic cancer cell death
Tesniere, A., Panaretakis, T., Kepp, O., Apetoh, L., Ghiringhelli, F., Zitvogel, L., & Kroemer, G. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402269 · Cited by 494
Obeid, M., Panaretakis, T., Joza, N., Tufi, R., Tesniere, A., van Endert, P., Zitvogel, L., & Kroemer, G. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402201 · Cited by 474
Duan, X., Chan, C., Guo, N., Han, W., Weichselbaum, R. R., & Lin, W. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b09538 · Cited by 458
Self-citationNon-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines
Zhang, Y., Jeon, M., Rich, L. J., Hong, H., Geng, J., Zhang, Y., Shi, S., Barnhart, T. E., Alexandridis, P., Huizinga, J. D., et al. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.130 · Cited by 442
Wang, D., Wang, T., Liu, J., Yu, H., Jiao, S., Feng, B., Zhou, F., Fu, Y., Yin, Q., Zhang, P., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b01994 · Cited by 405
Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
Zitvogel, L., Kepp, O., Senovilla, L., Menger, L., Chaput, N., & Kroemer, G. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2891 · Cited by 387
Cancer hyperthermia using magnetic nanoparticles
Kobayashi, T. (2011) · Biotechnology Journal · doi:10.1002/biot.201100045 · Cited by 354
Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
Kuai, R., Yuan, W., Son, S., Nam, J., Xu, Y., Fan, Y., Schwendeman, A., & Moon, J. J. (2018) · Science Advances · doi:10.1126/sciadv.aao1736 · Cited by 352
Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments
Inoue, H., & Tani, K. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.84 · Cited by 347
The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
Panaretakis, T., Joza, N., Modjtahedi, N., Tesniere, A., Vitale, I., Durchschlag, M., Fimia, G. M., Kepp, O., Piacentini, M., Froehlich, K.-U., et al. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.67 · Cited by 344
Radiation as an immunological adjuvant: current evidence on dose and fractionation
Demaria, S., & Formenti, S. C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00153 · Cited by 332
Lipoprotein-Inspired Nanoparticles for Cancer Theranostics
Ng, K. K., Lovell, J. F., & Zheng, G. (2011) · Accounts of Chemical Research · doi:10.1021/ar200017e · Cited by 330
Song, W., Kuang, J., Li, C.-X., Zhang, M., Zheng, D., Zeng, X., Liu, C., & Zhang, X.-Z. (2018) · ACS Nano · doi:10.1021/acsnano.7b09112 · Cited by 314
The convergence of radiation and immunogenic cell death signaling pathways
Golden, E. B., Pellicciotta, I., Demaria, S., Barcellos-Hoff, M. H., & Formenti, S. C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00088 · Cited by 282
Zhao, X., Yang, K., Zhao, R., Ji, T., Wang, X., Yang, X., Zhang, Y., Cheng, K., Liu, S., Hao, J., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.032 · Cited by 256
Inducers of immunogenic cancer cell death
Dudek, A. M., Garg, A. D., Krysko, D. V., De Ruysscher, D., & Agostinis, P. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.01.005 · Cited by 250
Chen, T., Guo, J., Han, C., Yang, M., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1449 · Cited by 236
Zheng, G., Chen, J., Li, H., & Glickson, J. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508677102 · Cited by 226
Yata, T., Takahashi, Y., Tan, M., Nakatsuji, H., Ohtsuki, S., Murakami, T., Imahori, H., Umeki, Y., Shiomi, T., Takakura, Y., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.014 · Cited by 220
Suzuki, Y., Mimura, K., Yoshimoto, Y., Watanabe, M., Ohkubo, Y., Izawa, S., Murata, K., Fujii, H., Nakano, T., & Kono, K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0851 · Cited by 219
Nishikawa, M., Mizuno, Y., Mohri, K., Matsuoka, N., Rattanakiat, S., Takahashi, Y., Funabashi, H., Luo, D., & Takakura, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.013 · Cited by 218
Liu, Y., Qiao, L., Zhang, S., Wan, G., Chen, B., Zhou, P., Zhang, N., & Wang, Y. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.11.010 · Cited by 218
Irradiation Promotes an M2 Macrophage Phenotype in Tumor Hypoxia
Chiang, C.-S., Fu, S. Y., Wang, S.-C., Yu, C.-F., Chen, F.-H., Lin, C.-M., & Hong, J.-H. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00089 · Cited by 217
Ito, A., Tanaka, K., Kondo, K., Shinkai, M., Honda, H., Matsumoto, K., Saida, T., & Kobayashi, T. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01438.x · Cited by 216
Immuno-thermal ablations – boosting the anticancer immune response
Slovak, R., Ludwig, J. M., Gettinger, S. N., Herbst, R. S., & Kim, H. S. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0284-8 · Cited by 205
Antitumor immunologically modified carbon nanotubes for photothermal therapy
Zhou, F., Wu, S., Song, S., Chen, W. R., Resasco, D. E., & Xing, D. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.029 · Cited by 203
Toraya-Brown, S., Sheen, M. R., Zhang, P., Chen, L., Baird, J. R., Demidenko, E., Turk, M. J., Hoopes, P. J., Conejo-Garcia, J. R., & Fiering, S. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.01.011 · Cited by 193
Yu, X., Gao, D., Gao, L., Lai, J., Zhang, C., Zhao, Y., Zhong, L., Jia, B., Wang, F., Chen, X., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b04736 · Cited by 192
Antitumor Immunity Induction by Intracellular Hyperthermia Using Magnetite Cationic Liposomes
Yanase, M., Shinkai, M., Honda, H., Wakabayashi, T., Yoshida, J., & Kobayashi, T. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb03283.x · Cited by 181
Functions of Heat Shock Proteins in Pathways of the Innate and Adaptive Immune System
Binder, R. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401417 · Cited by 175
Functionalization of cobalt porphyrin–phospholipid bilayers with his-tagged ligands and antigens
Shao, S., Geng, J., Ah Yi, H., Gogia, S., Neelamegham, S., Jacobs, A., & Lovell, J. F. (2015) · Nature Chemistry · doi:10.1038/nchem.2236 · Cited by 158
Biomimetic Nanocarrier for Direct Cytosolic Drug Delivery
Zhang, Z., Cao, W., Jin, H., Lovell, J. F., Yang, M., Ding, L., Chen, J., Corbin, I., Luo, Q., & Zheng, G. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200903112 · Cited by 158
Sau, S., Alsaab, H. O., Bhise, K., Alzhrani, R. M., Nabil, G., & Iyer, A. K. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.01.028 · Cited by 154
Prasad, S. J., Farrand, K. J., Matthews, S. A., Chang, J. H., McHugh, R. S., & Ronchese, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.90 · Cited by 153
Cano‐Mejia, J., Burga, R. A., Sweeney, E. E., Fisher, J. P., Bollard, C. M., Sandler, A. D., Cruz, C. C., & Fernandes, R. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.10.015 · Cited by 148
Thong, P. S. P., Ong, K.-W., Goh, N. S.-G., Kho, K. W., Manivasager, V., Ramaswamy, B., Olivo, M., & Soo, K. C. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70318-2 · Cited by 146
Liu, Y., Maccarini, P. F., Palmer, G. M., Etienne, W., Zhao, Y., Lee, C.-T., Ma, X., Inman, B. A., & Vo‐Dinh, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-09116-1 · Cited by 144
Tao, Y., Ju, E., Liu, Z., Dong, K., Ren, J., & Qu, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.073 · Cited by 143
Vergara, D., Bellomo, C., Zhang, X., Vergaro, V., Tinelli, A., Lorusso, V., Rinaldi, R., LVOV, Y. M., Leporatti, S., & Maffia, M. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.10.014 · Cited by 124
Li, L., Yang, S., Song, L., Zeng, Y., He, T., Wang, N., Yu, C., Yin, T., Liu, L., Wei, X., et al. (2017) · Theranostics · doi:10.7150/thno.19826 · Cited by 122
CpG loaded MoS 2 nanosheets as multifunctional agents for photothermal enhanced cancer immunotherapy
Han, Q., Wang, X., Jia, X., Cai, S., Liang, W. P., Qin, Y., Yang, R., & Wang, C. (2017) · Nanoscale · doi:10.1039/c7nr01460k · Cited by 120
Highly Integrated Nano-Platform for Breaking the Barrier between Chemotherapy and Immunotherapy
Zheng, D., Chen, J., Zhu, J., Rong, L., Li, B., Lei, Q., Fan, J., Zou, M., Li, C., Cheng, S., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b01432 · Cited by 117
Kawai, N., Itô, A., Nakahara, Y., Futakuchi, M., Shirai, T., Honda, H., Kobayashi, T., & Kohri, K. (2005) · The Prostate · doi:10.1002/pros.20253 · Cited by 116
Combinatorial immunotherapy and nanoparticle mediated hyperthermia
Moy, A. J., & Tunnell, J. W. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.008 · Cited by 114
Antitumor Immunity by Magnetic Nanoparticle-Mediated Hyperthermia
Kobayashi, T., Kakimi, K., Nakayama, E., & Jimbow, K. (2014) · Nanomedicine · doi:10.2217/nnm.14.106 · Cited by 110
Regulatory T Cells in Radiotherapeutic Responses
Schaue, D., Xie, M. W., Ratikan, J. A., & McBride, W. H. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00090 · Cited by 99
Jo, S. D., Nam, G., Kwak, G., Yang, Y., & Kwon, I. C. (2017) · Nano Today · doi:10.1016/j.nantod.2017.10.008 · Cited by 91
Vanpouille‐Box, C., Lacœuille, F., Daviaud, C., Lepareur, N., Lemaire, L. P., Lejeune, J.-J., Benoît, J., Meneï, P., Couturier, O., Garcion, E., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.067 · Cited by 88
How Does Ionizing Irradiation Contribute to the Induction of Anti-Tumor Immunity?
Rubner, Y., Wunderlich, R., Rühle, P.-F., Kulzer, L., Werthmöller, N., Frey, B., Weiss, E., Keilholz, L., Fietkau, R., & Gaipl, U. S. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00075 · Cited by 84
Nanoparticle design to induce tumor immunity and challenge the suppressive tumor microenvironment
Dewitte, H., Verbeke, R., Breckpot, K., Smedt, S. C. D., & Lentacker, I. (2014) · Nano Today · doi:10.1016/j.nantod.2014.10.001 · Cited by 72
Seth, A., Heo, M. B., & Lim, Y. T. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.076 · Cited by 70
Roy, A., Singh, M. S., Upadhyay, P. K., & Bhaskar, S. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.045 · Cited by 69
Kumar, P., & Srivastava, R. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.08.006 · Cited by 66
Hong, E., & Dobrovolskaia, M. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.005 · Cited by 61
Therapeutic cancer vaccine survives biotech bust
Ledford, H. K. (2015) · Nature · doi:10.1038/nature.2015.16990 · Cited by 51
A Combined Chemoimmunotherapy Approach Using a Plasmid−Doxorubicin Complex
Bagalkot, V., Lee, I., Yu, M. K., Lee, E., Park, S., Lee, J.-H., & Jon, S. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800177f · Cited by 49
Su, B., Cengizeroglu, A., Farkasova, K., Viola, J. R., Anton, M., Ellwart, J. W., Haase, R., Wagner, E., & Ogris, M. (2013) · Molecular Therapy · doi:10.1038/mt.2012.229 · Cited by 45
Lim, Y. T., Heo, M. B., Kim, S. Y., & Yun, W. S. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s90104 · Cited by 43
Activation of inflammasomes by tumor cell death mediated by gold nanoshells
Nguyen, H. T., Tran, K. K., Sun, B., & Shen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.063 · Cited by 43
Stangl, S., Themelis, G., Friedrich, L., Ntziachristos, V., Sarantopoulos, A., Molls, M., Skerra, A., & Multhoff, G. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.051 · Cited by 36
Homma, T., & Fujii, J. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.10.006 · Cited by 34
Radiotherapy and immune checkpoint blockade: potential interactions and future directions
Binder, D. C., Fu, Y., & Weichselbaum, R. R. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.05.007 · Cited by 33
Roy, A., Chandra, S., Mamilapally, S., Upadhyay, P. K., & Bhaskar, S. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0756-y · Cited by 32
CpG plus radiotherapy: a review of preclinical works leading to clinical trial
Mason, K. A., & Hunter, N. R. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00101 · Cited by 30
Itô, A., Yamaguchi, M., Okamoto, N., 實松, 裕., Kawabe, Y., Wakamatsu, K., Ito, S., Honda, H., Kobayashi, T., Nakayama, E., et al. (2012) · Nanomedicine · doi:10.2217/nnm.12.142 · Cited by 23
Biomimetic Nanocarrier for Direct Cytosolic Drug Delivery
Zhang, Z., Cao, W., Jin, H., Lovell, J. F., Yang, M., Ding, L., Chen, J., Corbin, I. R., Luo, Q., & Zheng, G. (2009) · Angewandte Chemie · doi:10.1002/ange.200903112 · Cited by 22
Chimeric antigen receptor T cells for ALL
Amrolia, P. J., & Pulè, M. A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61729-3 · Cited by 20
Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity
Vanpouille‐Box, C., & Hindré, F. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00136 · Cited by 16
Jimbow, K., Ishii‐Osai, Y., Ito, S., Tamura, Y., Itô, A., Yoneta, A., Kamiya, T., Yamashita, T., Honda, H., Wakamatsu, K., et al. (2013) · Journal of Skin Cancer · doi:10.1155/2013/742925 · Cited by 15
Jimbow, K. (2012) · Journal of Biomaterials and Nanobiotechnology · doi:10.4236/jbnb.2012.32020 · Cited by 12
Research works printed but not linked: 13
- Hong E., 2018, Adv. Drug Deliv. Rev.
- Yanase M., 1998, Cancer Sci., 89, 775
- Jimbow K., 2013, J. Skin Cancer, 2013
- 10.1038/sj.cgt.7700648 · doi:10.1038/sj.cgt.7700648
- 10.1007/s00262-003-0416-5 · doi:10.1007/s00262-003-0416-5
- 10.1016/j.biomaterials.2014.08.036 · doi:10.1016/j.biomaterials.2014.08.036
- 10.1039/C2IB20125A · doi:10.1039/c2ib20125a
- 10.1007/s11060-016-2289-4 · doi:10.1007/s11060-016-2289-4
- Jestin E., 2007, Q. J. Nucl. Med. Mol. Imaging, 51, 51
- 10.1371/journal.pone.0016926 · doi:10.1371/journal.pone.0016926
- 10.1016/j.jconrel.2009.09.014 · doi:10.1016/j.jconrel.2009.09.014
- 10.1021/mp100153r · doi:10.1021/mp100153r
- Heo M. B., 2015, Int. J. Nanomed., 10, 5981
Cited by
Enhancing cancer immunotherapy with nanomedicine
Irvine, D. J., & Dane, E. L. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0269-6 · Cited by 882
Li, Z., Lai, X., Fu, S., Ren, L., Cai, H., Zhang, H., Gu, Z., Ma, X., & Luo, K. (2022) · Advanced Science · doi:10.1002/advs.202201734 · Cited by 680
Yang, B., Chen, Y., & Shi, J. (2019) · Advanced Materials · doi:10.1002/adma.201901778 · Cited by 601
Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy
Ji, B., Wei, M., & Yang, B. (2022) · Theranostics · doi:10.7150/thno.67300 · Cited by 544
Chen, C., Ni, X., Jia, S., Liang, Y., Wu, X., Kong, D., & Ding, D. (2019) · Advanced Materials · doi:10.1002/adma.201904914 · Cited by 503
Metadata
- Authors
- Duan, X., Chan, C., & Lin, W.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2018-11-15
- Volume
- 58
- Issue
- 3
- Pages
- 670-680
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2883164386
- Cited by
- 1,033
- References
- 120
- FWCI
- 24.68
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- National Cancer Institute (U01-CA198989, 1R01CA216436)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.